期刊文献+

氢质子磁共振波谱在乳腺良恶性病变诊断中的价值探讨 被引量:2

Value of 1H-MRS in the diagnosis of breast lesions
下载PDF
导出
摘要 目的:研究乳腺氢质子磁共振波谱(1H-MRS)的特点,评估其在鉴别乳腺良恶性病变中的价值。方法回顾性分析有明确病理结果且波谱采集成功的55个乳腺病灶(恶性37个、良性18个)及10个健康腺体的1H-MRS特点。结果37个恶性病灶中有28个在3.22×10^-6处出现胆碱(Cho)峰,9个未出现Cho峰;18个良性病灶有3个在3.22×10^-6处出现Cho峰,其他15个良性病灶和10个健康腺体都未出现Cho峰。以Cho峰鉴别良恶性病变的敏感度76%(28/37),特异度83%(15/18),阳性预测值90%(28/31),阴性预测值63%(15/24)。差异有统计学意义(Kappa=0.781,P<0.01)。1H-MRS阳性病例中,病灶最大径>2.5 cm占48%(15/31),2.0-2.5 cm占42%(13/31),1.5-2.0 cm为10%(3/31)。结论1H-MRS对乳腺肿瘤的敏感性及特异性较高,对病灶>1.5 cm的乳腺肿块性病变,可用1H-MRS协助鉴别病变的良恶性。 Objective To study the features of breast proton magnetic resonance spectroscopy ( 1H-MRS), as-sessing its value on differentiating bengin from malignant lesions. Methods Retrospective analysis on 55 breast le-sions (37 malignant cases,18 benign cases) and 10 normal glands which had specific pathological results and spectral acquisition success, study the 1H-MRS features of them. Results Of 37 malignant lesions, Choline (Cho) peak ap-peared at 3.22×10^-6 in 28 items, 9 items didn′t have Cho peak;of 18 benign lesions, Cho peak appeared at 3.22×10^-6 in 3 items, the other 15 benign lesions and 10 normal glands didn′t obtain Cho peak. The sensitivity, specificity, pos-itive predictive value, negative predictive value of Cho peak on differentiate benign from malignant lesions was 76%(28/37), 83%(15/18), 90%(28/31), 63%(15/24) respectively, which had statistically significance (Kappa=0.781, P=0.000). The maximum diameters of positive 1H-MRS cases were 〉2.5 cm, 2.0-2.5 cm, and 1.5-2.0 cm, accounting for 48% (15/31), 42%(13/31) and 10%(3/31) respectively. Conclusion 1H-MRS have a relatively higher sensitivity and specificity for breast tumors, which can be used to help identify benign or malignant lesions for breast mass〉1.5 cm.
出处 《实用医学影像杂志》 2014年第2期95-97,共3页 Journal of Practical Medical Imaging
关键词 乳腺疾病 磁共振成像 磁共振波谱学 诊断 Breast diseases Magnetic resonance imaging Magnetic resonance spectroscopy Diagnosis
  • 相关文献

参考文献10

  • 1Tozaki M, Fukuma E. H-MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? [J]. Radiology,2009,193(9):840- 849.
  • 2Sardanelli F,Fausto A,Di-Leo G,et al. In vivo proton MR spee- troscopy of the breast using the total choline peak integral as a marker of malignancy[J]. Radiology,2009,192(6) : 1608-1617.
  • 3Manton DJ,Chaturvedi A,Hubbard A,et al. Neo-adjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy[J]. Radiology,2006, 94(5) :427-435.
  • 4赵斌,蔡世峰,于台飞,彭洪娟,李慧华.MR氢质子波谱在乳腺肿块应用中的价值及技术干扰因素分析[J].中华放射学杂志,2006,40(3):281-284. 被引量:32
  • 5Huang W,Fisher PR,Dulaimy K,et al. Detection of breast malignancy: diagnostic MR protocol for improved specificity[J]. Radiology, 2004,232 ( 2 ) : 585 -591.
  • 6Tse GM, Cheang HS,Pang LM,et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carci- nomas, benign lesions, and phyllodes tumors[J]. AJR,2003, 181 (5) : 1267-1272.
  • 7Yeung DK,Cheung HS, Tse GM. Human breast lesions: char- acteHzation with contrast enhanced in vivo proton MR spec- troscopy initial results[J]. Radiology, 2001,220( 1 ) :40-46.
  • 8Bartella L,Morris EA,Dershaw DD,et al. Proton MR spec- troscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study[J]. Radiology,2006,239(3) :686-692.
  • 9Jacobs MA,Barker PB,Argani P,et al. Combined dynamic con- trast enhanced breast MR and proton spectroscopic imaging: a feasibility study[J]. Magn Reson Imaging, 2005,21 (1) : 23-26.
  • 10Jagannathan NR,Seenu V,Kumar M. Potential of in vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent [ J]. Radiology, 2002,223 ( 1 ) : 281-282.

二级参考文献11

  • 1Sinha S,Lucas-Quesada FA,DeBruhl ND,et al.Multifeature analysis of Gd-enhanced MR images of breast lesions.J Magn Reson Imaging,1997,7:1016-1026.
  • 2Kuhl CK,Mielcareck P,Klaschik S,et al.Dynamic breast MR imaging:are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology,1999,211:101-110.
  • 3Brinck U,Fischer U,Korabiowska M,et al.The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.AJR,1997,168:1331-1334.
  • 4Negendank W.Studies of human tumors by MRS:a review (Review).NMR Biomed,1992,5:303-324.
  • 5Cecil KM,Schnall MD,Siegelman ES,et al.The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.Breast Cancer Res Treat,2001,68:45-54.
  • 6Katz-Brull R,Lavin PT,Lenkinski RE.Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions(Review).J Natl Cancer Inst,2002,94:1197-1203.
  • 7Kvistad KA,Bakken IJ,Gribbestad IS,et al.Characterization of neoplastic and normal human breast tissues with in vivo 1H-MR spectroscopy.J Magn Reson Imaging,1999,10:159-164.
  • 8Roebuck JR,Cecil KM,Schnall MD,et al.Human breast lesions:characterization with proton MR spectroscopy.Radiology,1998,209:269-275.
  • 9Mackinnon WB,Barry PA,Malycha PL,et al.Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.Radiology,1997,204:661-666.
  • 10Jagannathan NR,Seenu V,Kumar M.Potential of in Vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent.Radiology,2002,223:281-282.

共引文献31

同被引文献31

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部